Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Pirtobrutinib After Covalent BTK Inhibitor - Double Refractory CLL
Pirtobrutinib After Covalent BTK Inhibitor - Double Refractory CLL
Author
Oncology Times
Published
Thu 18 Jan 2024
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT_POD_EP55_010924.mp3
Share to:
